Skip to main content
. 2021 Sep 27;13(9):1012–1024. doi: 10.4240/wjgs.v13.i9.1012

Table 3.

Factors affecting recurrence-free interval of participants

Factors Univariate
Multivariate
OR (95%CI)
P value
OR (95%CI)
P value
Age (yr) 0.995 (0.987–1.002) 0.165 0.999 (0.991–1.006) 0.715
Sex 0.907 (0.765–1.076) 0.262
Surveillance intensity 2.218 (1.870–2.632) < 0.001 1.999 (1.680–2.377) < 0.001
Differentiation
WD/MD Ref. Ref.
PD/SRC/MUC 1.507 (1.151–1.974) 0.003 1.287 (0.979–1.694) 0.071
(y) pT stage
0–2 Ref. Ref.
3–4 2.118 (1.610–2.785) < 0.001 1.596 (1.197–2.127) 0.001
(y) pN stage
1c Ref. Ref.
1 2.737 (0.682–10.989) 0.156 2.501 (0.621–10.063) 0.197
2 5.260 (1.308–21.156) 0.019 3.813 (0.943–15.413) 0.060
Lymphovascular invasion 1.460 (1.236–1.724) < 0.001 1.143 (0.957–1.364) 0.140
Perineural invasion 1.949 (1.641–2.313) < 0.001 1.431 (1.192–1.719) < 0.001
Resection margin1 2.192 (1.529–3.144) < 0.001 1.565 (1.083–2.262) 0.017
1

Resection margin indicated circumferential resection margin, and were calculated with rectal cancer patients. OR: Odds ratio; CI: Confidence interval; Ref: Reference; WD: Well differentiated; MD: Moderately differentiated; PD: Poorly differentiated; SRC: Signet ring cell type; MUC: Mucinous carcinoma.